Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection - Increasing Community Access to Testing Program, United States, September-November 2022 User BillyGrier, in the COVID-19 subreddit, 02 Dec 2022
Omicron boosters offer additional protection against COVID-19 infection. When the updated booster was administered eight months or more after a person's last COVID-19 shot, the vaccine was 56% effective at preventing symptomatic disease in people ages 18-49, 48% among those ages 50-64 User Wagamaga, in the Reddit Science subreddit, 24 Nov 2022
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 User OkWolf53651, in the COVID-19 subreddit, 23 Nov 2022
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection User OkWolf53651, in the COVID-19 subreddit, 23 Nov 2022